v3.26.1
Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Operating expenses:    
Research and development $ 2,929,983 $ 8,203,691
Selling, general and administrative (including related party amounts of $645,250 and $0, respectively) 4,843,615 4,309,551
Total operating expenses 7,773,598 12,513,242
Loss from operations (7,773,598) (12,513,242)
Other income and expenses:    
Interest income 215,041 225,781
Net loss $ (7,558,557) $ (12,287,461)
Net loss per share of Common Stock, basic $ (8.16) $ (80.32)
Net loss per share of Common Stock, diluted $ (8.16) $ (80.32)
Weighted-average basic Common Stock 926,192 152,974
Weighted-average diluted Common Stock 926,192 152,974

Source